Nexalin's device administers a frequency-based waveform that is designed to treat patients in a pain-free and undetectable manner. The Gen-2 and Gen-3 stimulation techniques rely on strategically ...

On Thursday, Nexalin Technology, Inc (NASDAQ:NXL) (NASDAQ:NXLIW) announced results from a clinical trial of its Deep Intracranial Frequency Stimulation (DIFS) technology for mild Alzheimer’s disease.

The demand for reliable high-frequency communications continues to grow in response to the widespread deployment of 5G and the future development of 6G. Simultaneously, wireless local-area network ...

Longer, a renowned innovator in the field of 3D printing and laser engraving will unveil its latest creation: the Longer Nano on Kickstarter on February 22nd, 2024, at 10 AM ET. With a mission to ...